skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

Schmoll, Hans-Joachim, Prof ; Twelves, Chris, Prof ; Sun, Weijing, Prof ; O'Connell, Michael J, Prof ; Cartwright, Thomas, Prof ; McKenna, Edward, PharmD ; Saif, Muhammad, Prof ; Lee, Steve, PhD ; Yothers, Greg, Prof ; Haller, Daniel, Prof

The lancet oncology, 2014-12, Vol.15 (13), p.1481-1492 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors
Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors

SINICROPE, Frank A ; FOSTER, Nathan R ; SARGENT, Daniel J ; O'CONNELL, Michael J ; RANKIN, Cathryn

Clinical cancer research, 2010-03, Vol.16 (6), p.1884-1893 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
3
Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer
Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer

Dignam, James J. ; Polite, Blase N. ; Yothers, Greg ; Raich, Peter ; Colangelo, Linda ; O'Connell, Michael J. ; Wolmark, Norman

JNCI : Journal of the National Cancer Institute, 2006-11, Vol.98 (22), p.1647-1654 [Periódico revisado por pares]

Cary, NC: Oxford University Press

Texto completo disponível

Citações Citado por
4
Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08
Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08
Material Type:
Artigo 		Adicionar ao Meu Espaço

Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08

POGUE-GEILE, Kay ; YOTHERS, Greg ; ALLEGRA, Carmen ; PETRELLI, Nicholas ; O'CONNELL, Michael J ; WOLMARK, Norman ; SOONMYUNG PAIK ; TANIYAMA, Yusuke ; TANAKA, Noriko ; GAVIN, Patrick ; COLANGELO, Linda ; BLACKMON, Nicole ; LIPCHIK, Corey ; KIM, Seong Rim ; SHARIF, Saima

JNCI : Journal of the National Cancer Institute, 2013-07, Vol.105 (13), p.989-992 [Periódico revisado por pares]

Cary, NC: Oxford University Press

Texto completo disponível

Citações Citado por
5
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

YOTHERS, Greg ; O'CONNELL, Michael J ; ALLEGRA, Carmen J ; PHILIP KUEBLER, J ; COLANGELO, Linda H ; PETRELLI, Nicholas J ; WOLMARK, Norman

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3768-3774 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

Allegra, Carmen J ; Yothers, Greg ; O'Connell, Michael J ; Beart, Robert W ; Wozniak, Timothy F ; Pitot, Henry C ; Shields, Anthony F ; Landry, Jerome C ; Ryan, David P ; Arora, Amit ; Evans, Lisa S ; Bahary, Nathan ; Soori, Gamini ; Eakle, Janice F ; Robertson, John M ; Moore, Jr, Dennis F ; Mullane, Michael R ; Marchello, Benjamin T ; Ward, Patrick J ; Sharif, Saima ; Roh, Mark S ; Wolmark, Norman

JNCI : Journal of the National Cancer Institute, 2015-11, Vol.107 (11), p.djv248 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
7
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

Wagner, Anna D ; Grothey, Axel ; Andre, Thierry ; Dixon, Jesse G ; Wolmark, Norman ; Haller, Daniel G ; Allegra, Carmen J ; de Gramont, Aimery ; VanCutsem, Eric ; Alberts, Steven R ; George, Thomas J ; O’Connell, Michael J ; Twelves, Christopher ; Taieb, Julien ; Saltz, Leonard B ; Blanke, Charles D ; Francini, Edoardo ; Kerr, Rachel ; Yothers, Greg ; Seitz, Jean F ; Marsoni, Silvia ; Goldberg, Richard M ; Shi, Qian

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.113 (4), p.400-407 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
8
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
Material Type:
Artigo 		Adicionar ao Meu Espaço

Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number

Lyons, Jonathan J ; Yu, Xiaomin ; Hughes, Jason D ; Le, Quang T ; Jamil, Ali ; Bai, Yun ; Ho, Nancy ; Zhao, Ming ; Liu, Yihui ; O'Connell, Michael P ; Trivedi, Neil N ; Nelson, Celeste ; DiMaggio, Thomas ; Jones, Nina ; Matthews, Helen ; Lewis, Katie L ; Oler, Andrew J ; Carlson, Ryan J ; Arkwright, Peter D ; Hong, Celine ; Agama, Sherene ; Wilson, Todd M ; Tucker, Sofie ; Zhang, Yu ; McElwee, Joshua J ; Pao, Maryland ; Glover, Sarah C ; Rothenberg, Marc E ; Hohman, Robert J ; Stone, Kelly D ; Caughey, George H ; Heller, Theo ; Metcalfe, Dean D ; Biesecker, Leslie G ; Schwartz, Lawrence B ; Milner, Joshua D

Nature genetics, 2016-12, Vol.48 (12), p.1564-1569 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

ALLEGRA, Carmen J ; YOTHERS, Greg ; O'REILLY, Seamus ; CHU, Luis ; AZAR, Catherine A ; LOPA, Samia ; WOLMARK, Norman ; O'CONNELL, Michael J ; SHARIF, Saima ; PETRELLI, Nicholas J ; COLANGELO, Linda H ; ATKINS, James N ; SEAY, Thomas E ; FEHRENBACHER, Louis ; GOLDBERG, Richard M

Journal of clinical oncology, 2011-01, Vol.29 (1), p.11-16 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer
Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer

Allegra, Carmen J ; Yothers, Greg ; O'Connell, Michael J ; Sharif, Saima ; Colangelo, Linda H ; Lopa, Samia H ; Petrelli, Nicholas J ; Goldberg, Richard M ; Atkins, James N ; Seay, Thomas E ; Fehrenbacher, Louis ; O'Reilly, Seamus ; Chu, Luis ; Azar, Catherine A ; Wolmark, Norman

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3385-3390 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (2.109)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (2.168)
  2. magazinearticle  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1984  (24)
  2. 1984Até1993  (71)
  3. 1994Até2003  (327)
  4. 2004Até2014  (900)
  5. Após 2014  (848)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (2.167)
  2. Japonês  (360)
  3. Norueguês  (3)
  4. Alemão  (2)
  5. Português  (1)
  6. Persa  (1)
  7. Russo  (1)
  8. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.